Article info

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries

Authors

  • Jessica Ochalek Centre for Health Economics, University of York, York, United Kingdom PubMed articlesGoogle scholar articles
  • Kaja Abbas Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom PubMed articlesGoogle scholar articles
  • Karl Claxton Centre for Health Economics, University of York, York, United Kingdom PubMed articlesGoogle scholar articles
  • Mark Jit Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United KingdomModelling and Economics Unit, Public Health England, London, United KingdomSchool of Public Health, University of Hong Kong, Hong Kong Special Administrative Region, China PubMed articlesGoogle scholar articles
  • James Lomas Centre for Health Economics, University of York, York, United Kingdom PubMed articlesGoogle scholar articles
  1. Correspondence to Jessica Ochalek; jessica.ochalek{at}york.ac.uk
View Full Text

Citation

Ochalek J, Abbas K, Claxton K, et al
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries

Publication history

  • Received May 28, 2020
  • Revised August 17, 2020
  • Accepted August 19, 2020
  • First published October 20, 2020.
Online issue publication 
October 20, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.